Alma Lasers gets FDA clearance for its award winning Soprano ICE platform

2023-04-17 04:00:42 By : Ms. Elsa Chan

Alma Lasers Receives New FDA Clearance on its Award Winning Soprano ICE Platform, the Gold Standard in Laser Hair Removal, Signaling a New Era in Aesthetic Technology Advancement

Alma Lasers, a subsidiary of Sisram Medical Ltd the leading global innovator of laser light-based, radiofrequency and ultrasound solutions for the aesthetic and surgical markets and  leading providers of energy-based surgical and medical aesthetic solutions in the Peoples Republic of China, launches the Soprano ICE Platinum. It is the first integrated solution that combines 3 wavelengths into one compact applicator (Trio) for superior clinical outcomes. Alma Soprano Platinum

The Soprano ICE Platinum is the only platform in the U.S that offers simultaneous emission of three wavelengths, 755, 810, and 1064 to target different tissue depths covering the optimal spectrum.

The Soprano ICE leads the way as the gold standard in virtually pain free laser hair removal technology and lesions with its proven safety record and ability to treat all skin types including tanned skin.

By incorporating multiple laser wavelengths and technologies, Soprano ICE allows practitioners to treat the widest range of patients, hair types and lesions all year round, administer treatments quickly and comfortably and achieve the best possible clinical results.

In the U.S., according to the American Society for Aesthetic Plastic Surgeons (ASAPS), over one million treatments were performed in 2016. Laser hair removal was ranked as the number 3 leading non-surgical treatment in the U.S.

How Plausible is Ending TB ...

APAC FemTech Space Gains Mo...

Can Med Tourism Industry hi...

The New Pandemic of Layoffs...

Can Technology Efface Sleep Disorde

Big Pharma’s Green Ambitions

ADVANcing Clinical Evidence in Infe

Australia invests $10 M for mRNA me

CPHI & PMEC China 2023 to attract o

Private & public sectors discuss co

Japan bags new opportunity to impro

Can Asian countries eliminate TB by 2030?

1 North Bridge Road, #08-08 High Street Centre, Singapore 179094 Email : communications@biospectrumasia.com +65 90150305

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer

Endospheres Therapy Machine Web Interface Conceived and Powered By : SCI Knowledge Interlinks